Developing Oral LT3 Therapy for Heart Failure - HFrEF

NCT04112316 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure With Reduced Ejection Fraction (HFrEF)
Low T3 Syndrome

Interventions

DRUG: Liothyronine
OTHER: Placebo

Sponsor

University of Pennsylvania

Collaborators

[object Object]